EWTX

39.9402.99%
MP

Michael P. Nofi

Chief Financial Officer

Mr. Michael P. Nofi has been Chief Financial Officer of Edgewise Therapeutics, Inc. since November 10, 2025. He had been Chief Accounting Officer of SpringWorks Therapeutics, Inc. since March 12, 2020. Mr. Nofi served Chief Financial Officer for Perfumania Holdings, Inc. from April 2017 until October 2018. Mr. Nofi served as a Director in the financial operations practice of the Connor Group from July 2016 to March 2017. Mr. Nofi worked at The Nature’s Bounty Co. from October 2018 to November 2019, in various positions, including as Chief Accounting Officer from May 2019 to November 2019. Prior to the Connor Group, Mr. Nofi served as Vice President of Finance and Controller of Acorda Therapeutics, from January 2016 to June 2016. From 2014 to 2015, Mr. Nofi served as the Vice President, Global Internal Audit for Allergan, a leading integrated global specialty pharmaceutical company. Mr. Nofi held increasing roles of responsibilities in Corporate Finance at Forest Laboratories, including Assistant Vice President, Assistant Controller from 2010 to 2014. Mr. Nofi holds a B. S. in accounting and an M. B.A. from Villanova University and is a Certified Public Accountant.

Positions